跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bacopa monnieri extract
首页
药物
Bacopa monnieri extract
Bacopa monnieri extract
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS
EP 3820433 A1
申请人: NUCHIDO LTD
优先权: 2018
CN
EP
US
WO
5 件公开
Food supplement for use as coadjuvant in the prevention and treatment of cognitive decline associated with Alzheimer disease
US 12514893 B2
申请人: CRISTALFARMA S R L
优先权: 2021
CN
EP
US
4 件公开
COMPOSITION AND METHODS FOR ACTIVATING CELLULAR SIGNALING GENES IN INNATE INFLAMMATORY PATHWAYS
US 2024398693 A1
申请人: LIFEVANTAGE CORP
优先权: 2023
US
WO
4 件公开
US 20260165357 A1
申请人: LIFEVANTAGE CORP
优先权: 2025
US
FUNCTIONAL CHEWING GUM COMPRISING PHYTONUTRIENTS AND ADAPTOGENIC HERBS
EP 3672578 A1
申请人: BRILLIANTIQ AB
优先权: 2017
CN
EP
US
3 件公开
Topical compositions and methods for reducing oxidative stress
US 9289374 B2
申请人: LIFEVANTAGE CORP
优先权: 2014
CN
US
3 件公开
Process for producing enriched fraction from Bacopa monnieri extract for management of neurodegenerative disorders
US 12357924 B2
申请人: STAR HI HERBS PVT LTD
优先权: 2021
US
WO
3 件公开
Food supplement, for as adjuvant, for preventing vascular dementia
US 12324824 B2
申请人: CRISTALFARMA S R L
优先权: 2019
CN
US
2 件公开
Compositions and methods for activating cellular signaling pathways
US 11484563 B2
申请人: LIFEVANTAGE CORP
优先权: 2020
US
WO
2 件公开
BRAIN HEALTH SUPPLEMENTS
US 2023364117 A1
申请人: MELALEUCA INC
优先权: 2022
CN
US
2 件公开
SUPPLEMENT FOR USE IN THE TREATMENT OF SIDE EFFECTS ASSOCIATED WITH ANTI-EPILEPTIC DRUG THERAPY
WO 2025133725 A1
申请人: COR CON INT S R L
优先权: 2023
CN
WO
2 件公开
第 1 / 4 页
上一页
下一页
药物
反馈